FDA Approves Nexium For Use In Children Ages 1-11 Years
Mar 3rd 2008Drug InformationAcid Reflux/GERD
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
